ArticleInternational journal of clinical and experimental pathology2017
Lymphoepithelioma-like hepatocellular carcinoma: a case report with emphasis on the cytological features.
Article in International journal of clinical and experimental pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 8 citations in OpenAlex.
- Programmed cell death ligand 1 expression in a case of poorly differentiated lymphocyte-rich hepatocellular carcinoma.Clinical case reports · 2021Article
- A Case of Lymphocyte-Rich Hepatocellular Carcinoma in a Patient Who Was Treated for Colon Cancer.Journal of liver cancer · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lymphoepithelioma-like hepatocellular carcinoma (LEL-HCC) is a rare distinct histopathological subtype of HCC, which is characterized histopathologically by the presence of abundant lymphocytes around the neoplastic cells, and less than 50 cases have been reported. In this report, we describe the first cytological case of LEL-HCC. A 58-year-old Japanese male had an elevated serum alpha-fetoprotein (AFP) level, and computed tomography scan demonstrated a tumorous lesion with contrast enhancement in the liver, thus, surgical resection was performed. The Papanicolaou smear of the liver tumor demonstrated small clusters and trabeculae of large-sized polygonal cells in a background of an abundance of small lymphocytes. These tumor cells had a rich granular cytoplasm and large centrally located round to oval nuclei containing conspicuous nucleoli. Immunocytochemical analyses revealed that these cells were positive for AFP, glypican-3, and Hep-Par1. Histopathological study demonstrated LEL-HCC. The cytological features of the present case represent both lymphoepithelioma-like carcinoma and conventional HCC. The prognosis of LEL-HCC may be favorable. Therefore, the diagnosis of this type of tumor is important, and a cytological examination can provide useful information for diagnosis of LEL-HCC.
Indexed as
Identifiers
31966638PMC6965265W3013825951What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.